Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Genell Knatterud

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Chemicals & Drugs

Tissue Plasminogen Activator

Procedures

Concepts & Ideas

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Domanski Michael; Tian Xin; Fleg Jerome; Coady Sean; Gosen Christine; Kirby Ruth; Sachdev Vandana; Knatterud Genell; Braunwald Eugene
Pleiotropic effect of lovastatin, with and without cholestyramine, in the post coronary artery bypass graft (Post CABG) trial.
Spring Bonnie; Pagoto Sherry; Knatterud Genell; Kozak Andrea; Hedeker Donald
Examination of the analytic quality of behavioral health randomized clinical trials.
Dzavík Vladimír; Buller Christopher E; Lamas Gervasio A; Rankin James M; Mancini G B John; Cantor Warren J; Carere Ronald J; Ross John R; Atchison Deborah; Forman Sandra; Thomas Boban; Buszman Pawel; Vozzi Carlos; Glanz Anthony; Cohen Eric A; Meciar Peter; Devlin Gerald; Mascette Alice; Sopko George; Knatterud Genell L; Hochman Judith S;
Randomized trial of percutaneous coronary intervention for subacute infarct-related coronary artery occlusion to achieve long-term patency and improve ventricular function: the Total Occlusion Study of Canada (TOSCA)-2 trial.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Genell Knatterud (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2008: Domanski Michael; Tian Xin; Fleg Jerome; Coady Sean; Gosen Christine; Kirby Ruth; Sachdev Vandana; Knatterud Genell; Braunwald Eugene
Pleiotropic effect of lovastatin, with and without cholestyramine, in the post coronary artery bypass graft (Post CABG) trial.
The American journal of cardiology 2008;102(8):1023-7.
2007: Spring Bonnie; Pagoto Sherry; Knatterud Genell; Kozak Andrea; Hedeker Donald
Examination of the analytic quality of behavioral health randomized clinical trials.
Journal of clinical psychology 2007;63(1):53-71.
2006: Dzavík Vladimír; Buller Christopher E; Lamas Gervasio A; Rankin James M; Mancini G B John; Cantor Warren J; Carere Ronald J; Ross John R; Atchison Deborah; Forman Sandra; Thomas Boban; Buszman Pawel; Vozzi Carlos; Glanz Anthony; Cohen Eric A; Meciar Peter; Devlin Gerald; Mascette Alice; Sopko George; Knatterud Genell L; Hochman Judith S;
Randomized trial of percutaneous coronary intervention for subacute infarct-related coronary artery occlusion to achieve long-term patency and improve ventricular function: the Total Occlusion Study of Canada (TOSCA)-2 trial.
Circulation 2006;114(23):2449-57.
2006: Hochman Judith S; Lamas Gervasio A; Buller Christopher E; Dzavik Vladimir; Reynolds Harmony R; Abramsky Staci J; Forman Sandra; Ruzyllo Witold; Maggioni Aldo P; White Harvey; Sadowski Zygmunt; Carvalho Antonio C; Rankin Jamie M; Renkin Jean P; Steg P Gabriel; Mascette Alice M; Sopko George; Pfisterer Matthias E; Leor Jonathan; Fridrich Viliam; Mark Daniel B; Knatterud Genell L;
Coronary intervention for persistent occlusion after myocardial infarction.
The New England journal of medicine 2006;355(23):2395-407.
2006: Baughman R P; Judson M A; Teirstein A; Yeager H; Rossman M; Knatterud G L; Thompson B
Presenting characteristics as predictors of duration of treatment in sarcoidosis.
QJM : monthly journal of the Association of Physicians 2006;99(5):307-15.
2005: Hochman Judith S; Lamas Gervasio A; Knatterud Genell L; Buller Christopher E; Dzavik Vladimir; Mark Daniel B; Reynolds Harmony R; White Harvey D;
Design and methodology of the Occluded Artery Trial (OAT).
American heart journal 2005;150(4):627-42.
2005: Campeau Lucien; Lespérance Jacques; Bilodeau Luc; Fortier Annik; Guertin Marie-Claude; Knatterud Genell L
Effect of cholesterol lowering and cardiovascular risk factors on the progression of aortoiliac arteriosclerosis: a quantitative cineangiography study.
Angiology 2005;56(2):191-9.
2005: Barnard Juliana; Rose Cecile; Newman Lee; Canner Martha; Martyny John; McCammon Chuck; Bresnitz Eddy; Rossman Milt; Thompson Bruce; Rybicki Benjamin; Weinberger Steven E; Moller David R; McLennan Geoffrey; Hunninghake Gary; DePalo Louis; Baughman Robert P; Iannuzzi Michael C; Judson Marc A; Knatterud Genell L; Teirstein Alvin S; Yeager Henry; Johns Carol J; Rabin David L; Cherniack Reuben;
Job and industry classifications associated with sarcoidosis in A Case-Control Etiologic Study of Sarcoidosis (ACCESS).
Journal of occupational and environmental medicine / American College of Occupational and Environmental Medicine 2005;47(3):226-34.
2005: Cusick Michael; Meleth Annal D; Agrón Elvira; Fisher Marion R; Reed George F; Knatterud Genell L; Barton Franca B; Davis Matthew D; Ferris Frederick L; Chew Emily Y;
Associations of mortality and diabetes complications in patients with type 1 and type 2 diabetes: early treatment diabetic retinopathy study report no. 27.
Diabetes care 2005;28(3):617-25.
2004: Newman Lee S; Rose Cecile S; Bresnitz Eddy A; Rossman Milton D; Barnard Juliana; Frederick Margaret; Terrin Michael L; Weinberger Steven E; Moller David R; McLennan Geoffrey; Hunninghake Gary; DePalo Louis; Baughman Robert P; Iannuzzi Michael C; Judson Marc A; Knatterud Genell L; Thompson Bruce W; Teirstein Alvin S; Yeager Henry; Johns Carol J; Rabin David L; Rybicki Benjamin A; Cherniack Reuben;
A case control etiologic study of sarcoidosis: environmental and occupational risk factors.
American journal of respiratory and critical care medicine 2004;170(12):1324-30.
2004: Taylor Kent D; Scheuner Maren T; Yang Huiying; Wang Yaping; Haritunians Talin; Fischel-Ghodsian Nathan; Shah Prediman K; Forrester James S; Knatterud Genell; Rotter Jerome I
Lipoprotein lipase locus and progression of atherosclerosis in coronary-artery bypass grafts.
Genetics in medicine : official journal of the American College of Medical Genetics 2004;6(6):481-6.
2004: Hennekens Charles H; Knatterud Genell L; Pfeffer Marc A
Use of aspirin to reduce risks of cardiovascular disease in patients with diabetes: clinical and research challenges.
Diabetes care 2004;27(11):2752-4.
2004: Barton Franca B; Fong Donald S; Knatterud Genell L;
Classification of Farnsworth-Munsell 100-hue test results in the early treatment diabetic retinopathy study.
American journal of ophthalmology 2004;138(1):119-24.
2003: Lindquist Ruth; Dupuis Gilles; Terrin Michael L; Hoogwerf Byron; Czajkowski Susan; Herd J Alan; Barton Franca B; Tracy Mary Fran; Hunninghake Donald B; Treat-Jacobson Diane; Shumaker Sally; Zyzanski Steve; Goldenberg Irvin; Knatterud Genell L;
Comparison of health-related quality-of-life outcomes of men and women after coronary artery bypass surgery through 1 year: findings from the POST CABG Biobehavioral Study.
American heart journal 2003;146(6):1038-44.
2003: Davidson Karina W; Goldstein Michael; Kaplan Robert M; Kaufmann Peter G; Knatterud Genell L; Orleans C Tracy; Spring Bonnie; Trudeau Kimberlee J; Whitlock Evelyn P
Evidence-based behavioral medicine: what is it and how do we achieve it?
Annals of behavioral medicine : a publication of the Society of Behavioral Medicine 2003;26(3):161-71.
2003: Judson Marc A; Baughman Robert P; Thompson Bruce W; Teirstein Alvin S; Terrin Michael L; Rossman Milton D; Yeager Henry; McLennan Geoffrey; Bresnitz Eddy A; DePalo Louis; Hunninghake Gary; Iannuzzi Michael C; Johns Carol J; Moller David R; Newman Lee S; Rabin David L; Rose Cecile; Rybicki Benjamin A; Weinberger Steven E; Knatterud Genell L; Cherniak Reuben;
Two year prognosis of sarcoidosis: the ACCESS experience.
Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG / World Association of Sarcoidosis and Other Granulomatous Disorders 2003;20(3):204-11.
2003: Knatterud Genell L; White Carl; Geller Nancy L; Campeau Lucien; Forman Sandra A; Domanski Michael; Forrester James S; Gobel Fredarick L; Herd J Alan; Hickey Ann; Hoogwerf Byron J; Hunninghake Donald B; Terrin Michael L; Rosenberg Yves
Angiographic changes in saphenous vein grafts are predictors of clinical outcomes.
American heart journal 2003;145(2):262-9.
2002: Aversano Thomas; Aversano Lynnet T; Passamani Eugene; Knatterud Genell L; Terrin Michael L; Williams David O; Forman Sandra A;
Thrombolytic therapy vs primary percutaneous coronary intervention for myocardial infarction in patients presenting to hospitals without on-site cardiac surgery: a randomized controlled trial.
JAMA : the journal of the American Medical Association 2002;287(15):1943-51.
2002: Sheps David S; McMahon Robert P; Becker Lewis; Carney Robert M; Freedland Kenneth E; Cohen Jerome D; Sheffield David; Goldberg A David; Ketterer Mark W; Pepine Carl J; Raczynski James M; Light Kathleen; Krantz David S; Stone Peter H; Knatterud Genell L; Kaufmann Peter G
Mental stress-induced ischemia and all-cause mortality in patients with coronary artery disease: Results from the Psychophysiological Investigations of Myocardial Ischemia study.
Circulation 2002;105(15):1780-4.
2002: Knatterud Genell L
Management and conduct of randomized controlled trials.
Epidemiologic reviews 2002;24(1):12-25.
2001: Rybicki B A; Iannuzzi M C; Frederick M M; Thompson B W; Rossman M D; Bresnitz E A; Terrin M L; Moller D R; Barnard J; Baughman R P; DePalo L; Hunninghake G; Johns C; Judson M A; Knatterud G L; McLennan G; Newman L S; Rabin D L; Rose C; Teirstein A S; Weinberger S E; Yeager H; Cherniack R;
Familial aggregation of sarcoidosis. A case-control etiologic study of sarcoidosis (ACCESS).
American journal of respiratory and critical care medicine 2001;164(11):2085-91.
2001: Baughman R P; Teirstein A S; Judson M A; Rossman M D; Yeager H; Bresnitz E A; DePalo L; Hunninghake G; Iannuzzi M C; Johns C J; McLennan G; Moller D R; Newman L S; Rabin D L; Rose C; Rybicki B; Weinberger S E; Terrin M L; Knatterud G L; Cherniak R;
Clinical characteristics of patients in a case control study of sarcoidosis.
American journal of respiratory and critical care medicine 2001;164(10 Pt 1):1885-9.
2001: White C W; Gobel F L; Campeau L; Knatterud G L; Forman S A; Forrester J S; Geller N L; Herd J A; Hickey A; Hoogwerf B J; Hunninghake D B; Rosenberg Y; Terrin M L;
Effect of an aggressive lipid-lowering strategy on progression of atherosclerosis in the left main coronary artery from patients in the post coronary artery bypass graft trial.
Circulation 2001;104(22):2660-5.
2001: White C W; Campeau L; Canner P; Domanski M; Forrester J S; Gobel F L; Herd J A; Hoogwerf B J; Hunninghake D B; Knatterud G L; LoPresti F;
Lessons from the post coronary artery bypass graft study in evaluating and controlling technical variability in angiographic trials. Post CABG Investigators.
The American journal of cardiology 2001;87(1):40-3.
2000: Domanski M J; Borkowf C B; Campeau L; Knatterud G L; White C; Hoogwerf B; Rosenberg Y; Geller N L
Prognostic factors for atherosclerosis progression in saphenous vein grafts: the postcoronary artery bypass graft (Post-CABG) trial. Post-CABG Trial Investigators.
Journal of the American College of Cardiology 2000;36(6):1877-83.
2000: Knatterud G L; Rosenberg Y; Campeau L; Geller N L; Hunninghake D B; Forman S A; Forrester J S; Gobel F L; Herd J A; Hickey A; Hoogwerf B J; Terrin M L; White C
Long-term effects on clinical outcomes of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation in the post coronary artery bypass graft trial. Post CABG Investigators.
Circulation 2000;102(2):157-65.
2000: Wenger N K; Knatterud G L; Canner P L
Early risks of hormone therapy in patients with coronary heart disease.
JAMA : the journal of the American Medical Association 2000;284(1):41-3.
1999: Pepine C J; Mark D B; Bourassa M G; Chaitman B R; Davies R F; Knatterud G L; Forman S; Pratt C M; Sopko G; Conti C R
Cost estimates for treatment of cardiac ischemia (from the Asymptomatic Cardiac Ischemia Pilot [ACIP] study).
The American journal of cardiology 1999;84(11):1311-6.
1999: Stone P H; Thompson B; Zaret B L; Chaitman B; Gibson R S; Schweiger M J; Steingart R; Kirshenbaum J; Thompson C; Fung A; McCabe C H; Knatterud G L; Braunwald E
Factors associated with failure of medical therapy in patients with unstable angina and non-Q wave myocardial infarction. A TIMI-IIIB database study.
European heart journal 1999;20(15):1084-93.
1999: Campeau L; Hunninghake D B; Knatterud G L; White C W; Domanski M; Forman S A; Forrester J S; Geller N L; Gobel F L; Herd J A; Hoogwerf B J; Rosenberg Y
Aggressive cholesterol lowering delays saphenous vein graft atherosclerosis in women, the elderly, and patients with associated risk factors. NHLBI post coronary artery bypass graft clinical trial. Post CABG Trial Investigators.
Circulation 1999;99(25):3241-7.
1999: Pepine C J; Bourassa M G; Chaitman B R; Davies R F; Kerensky R A; Sharaf B; Knatterud G L; Forman S A; Pratt C M; Staples E D; Sopko G; Conti C R
Factors influencing clinical outcomes after revascularization in the asymptomatic cardiac ischemia pilot (ACIP). ACIP Study Group.
Journal of cardiac surgery 1999;14(1):1-8.
1998: Knatterud G L; Rockhold F W; George S L; Barton F B; Davis C E; Fairweather W R; Honohan T; Mowery R; O'Neill R
Guidelines for quality assurance in multicenter trials: a position paper.
Controlled clinical trials 1998;19(5):477-93.
1998: Sheps D S; McMahon R P; Pepine C J; Stone P H; Goldberg A D; Taylor H; Cohen J D; Becker L C; Chaitman B; Knatterud G L; Kaufmann P G
Heterogeneity among cardiac ischemic and anginal responses to exercise, mental stress, and daily life.
The American journal of cardiology 1998;82(1):1-6.
1998: Davis M D; Fisher M R; Gangnon R E; Barton F; Aiello L M; Chew E Y; Ferris F L; Knatterud G L
Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: Early Treatment Diabetic Retinopathy Study Report #18.
Investigative ophthalmology & visual science 1998;39(2):233-52.
1998: Carney R M; McMahon R P; Freedland K E; Becker L; Krantz D S; Proschan M A; Raczynski J M; Ketterer M W; Knatterud G L; Light K; Lindholm L; Sheps D S
Reproducibility of mental stress-induced myocardial ischemia in the Psychophysiological Investigations of Myocardial Ischemia (PIMI).
Psychosomatic medicine 1998;60(1):64-70.
1998: Kaufmann P G; McMahon R P; Becker L C; Bertolet B; Bonsall R; Chaitman B; Cohen J D; Forman S; Goldberg A D; Freedland K; Ketterer M W; Krantz D S; Pepine C J; Raczynski J; Stone P H; Taylor H; Knatterud G L; Sheps D S
The Psychophysiological Investigations of Myocardial Ischemia (PIMI) study: objective, methods, and variability of measures.
Psychosomatic medicine 1998;60(1):56-63.
1997: Stone P H; Chaitman B R; Forman S; Andrews T C; Bittner V; Bourassa M G; Davies R F; Deanfield J E; Frishman W; Goldberg A D; MacCallum G; Ouyang P; Pepine C J; Pratt C M; Sharaf B; Steingart R; Knatterud G L; Sopko G; Conti C R
Prognostic significance of myocardial ischemia detected by ambulatory electrocardiography, exercise treadmill testing, and electrocardiogram at rest to predict cardiac events by one year (the Asymptomatic Cardiac Ischemia Pilot [ACIP] study)
The American journal of cardiology 1997;80(11):1395-401.
1997: Campeau L; Knatterud G; Hunninghake B; Domanski M
Optimizing cholesterol lowering therapy: contribution of the Post Coronary Artery Bypass Graft Trial.
European heart journal 1997;18(11):1683-5.
1997: Canner P L; Thompson B; Knatterud G L; Geller N; Campeau L; Zucker D
An application of the Zucker-Wittes modified ratio estimate statistic in the Post Coronary Artery Bypass Graft (CABG) clinical trial.
Controlled clinical trials 1997;18(4):318-27.
1997: Hochman J S; McCabe C H; Stone P H; Becker R C; Cannon C P; DeFeo-Fraulini T; Thompson B; Steingart R; Knatterud G; Braunwald E
Outcome and profile of women and men presenting with acute coronary syndromes: a report from TIMI IIIB. TIMI Investigators. Thrombolysis in Myocardial Infarction.
Journal of the American College of Cardiology 1997;30(1):141-8.
1997: Sloan M A; Price T R; Terrin M L; Forman S; Gore J M; Chaitman B R; Hodges M; Mueller H; Rogers W J; Knatterud G L; Braunwald E
Ischemic cerebral infarction after rt-PA and heparin therapy for acute myocardial infarction. The TIMI-II pilot and randomized clinical trial combined experience.
Stroke; a journal of cerebral circulation 1997;28(6):1107-14.
1997: Pepine C J; Sharaf B; Andrews T C; Forman S; Geller N; Knatterud G; Mahmarian J; Ouyang P; Rogers W J; Sopko G; Steingart R; Stone P H; Conti C R
Relation between clinical, angiographic and ischemic findings at baseline and ischemia-related adverse outcomes at 1 year in the Asymptomatic Cardiac Ischemia Pilot study. ACIP Study Group.
Journal of the American College of Cardiology 1997;29(7):1483-9.
1997: Davies R F; Goldberg A D; Forman S; Pepine C J; Knatterud G L; Geller N; Sopko G; Pratt C; Deanfield J; Conti C R
Asymptomatic Cardiac Ischemia Pilot (ACIP) study two-year follow-up: outcomes of patients randomized to initial strategies of medical therapy versus revascularization.
Circulation 1997;95(8):2037-43.
1997: Czajkowski S M; Terrin M; Lindquist R; Hoogwerf B; Dupuis G; Shumaker S A; Gray J R; Herd J A; Treat-Jacobson D; Zyzanski S; Knatterud G L
Comparison of preoperative characteristics of men and women undergoing coronary artery bypass grafting (the Post Coronary Artery Bypass Graft [CABG] Biobehavioral Study).
The American journal of cardiology 1997;79(8):1017-24.
1997: Conti C R; Geller N L; Knatterud G L; Forman S A; Pratt C M; Pepine C J; Sopko G
Anginal status and prediction of cardiac events in patients enrolled in the asymptomatic cardiac ischemia pilot (ACIP) study. ACIP investigators.
The American journal of cardiology 1997;79(7):889-92.
1997: Bovill E G; Tracy R P; Knatterud G L; Stone P H; Nasmith J; Gore J M; Thompson B W; Tofler G H; Kleiman N S; Cannon C; Braunwald E
Hemorrhagic events during therapy with recombinant tissue plasminogen activator, heparin, and aspirin for unstable angina (Thrombolysis in Myocardial Ischemia, phase IIIB trial).
The American journal of cardiology 1997;79(4):391-6.
1996: Knatterud G; Greenhouse S W
Tributes to Dr. Thomas C. Chalmers.
Controlled clinical trials 1996;17(6):473-5.
1996: Becker L C; Pepine C J; Bonsall R; Cohen J D; Goldberg A D; Coghlan C; Stone P H; Forman S; Knatterud G; Sheps D S; Kaufmann P G
Left ventricular, peripheral vascular, and neurohumoral responses to mental stress in normal middle-aged men and women. Reference Group for the Psychophysiological Investigations of Myocardial Ischemia (PIMI) Study.
Circulation 1996;94(11):2768-77.
1996: Williams D O; Braunwald E; Thompson B; Sharaf B L; Buller C E; Knatterud G L
Results of percutaneous transluminal coronary angioplasty in unstable angina and non-Q-wave myocardial infarction. Observations from the TIMI IIIB Trial.
Circulation 1996;94(11):2749-55.
1996: Becker R C; Cannon C P; Bovill E G; Tracy R P; Thompson B; Knatterud G L; Randall A; Braunwald B
Prognostic value of plasma fibrinogen concentration in patients with unstable angina and non-Q-wave myocardial infarction (TIMI IIIB Trial)
The American journal of cardiology 1996;78(2):142-7.
1996: Pratt C M; McMahon R P; Goldstein S; Pepine C J; Andrews T C; Dyrda I; Frishman W H; Geller N L; Hill J A; Morgan N A; Stone P H; Knatterud G L; Sopko G; Conti C R
Comparison of subgroups assigned to medical regimens used to suppress cardiac ischemia (the Asymptomatic Cardiac Ischemia Pilot [ACIP] Study).
The American journal of cardiology 1996;77(15):1302-9.
1996: Stone P H; Thompson B; Anderson H V; Kronenberg M W; Gibson R S; Rogers W J; Diver D J; Théroux P; Warnica J W; Nasmith J B; Kells C; Kleiman N; McCabe C H; Schactman M; Knatterud G L; Braunwald E
Influence of race, sex, and age on management of unstable angina and non-Q-wave myocardial infarction: The TIMI III registry.
JAMA : the journal of the American Medical Association 1996;275(14):1104-12.
1995: Bourassa M G; Knatterud G L; Pepine C J; Sopko G; Rogers W J; Geller N L; Dyrda I; Forman S A; Chaitman B R; Sharaf B
Asymptomatic Cardiac Ischemia Pilot (ACIP) Study. Improvement of cardiac ischemia at 1 year after PTCA and CABG.
Circulation 1995;92(9 Suppl):II1-7.
1995: Mueller H S; Forman S A; Menegus M A; Cohen L S; Knatterud G L; Braunwald E
Prognostic significance of nonfatal reinfarction during 3-year follow-up: results of the Thrombolysis in Myocardial Infarction (TIMI) phase II clinical trial. The TIMI Investigators.
Journal of the American College of Cardiology 1995;26(4):900-7.
1995: Zaret B L; Wackers F J; Terrin M L; Forman S A; Williams D O; Knatterud G L; Braunwald E
Value of radionuclide rest and exercise left ventricular ejection fraction in assessing survival of patients after thrombolytic therapy for acute myocardial infarction: results of Thrombolysis in Myocardial Infarction (TIMI) phase II study. The TIMI Study Group.
Journal of the American College of Cardiology 1995;26(1):73-9.
1995: Knatterud G L; Meinart C
A tribute to Christian Robert Klimt (1918-1994).
Controlled clinical trials 1995;16(3):139-42.
1995: Gersh B J; Chesebro J H; Braunwald E; Lambrew C; Passamani E; Solomon R E; Ross A M; Ross R; Terrin M L; Knatterud G L
Coronary artery bypass graft surgery after thrombolytic therapy in the Thrombolysis in Myocardial Infarction Trial, Phase II (TIMI II).
Journal of the American College of Cardiology 1995;25(2):395-402.
1995: Conti C R; Bourassa M G; Chaitman B R; Geller N L; Knatterud G L; Pepine C J; Pratt C; Sopko G
Asymptomatic cardiac ischemia pilot (ACIP).
Transactions of the American Clinical and Climatological Association 1995;106():77-83; discussion 83-4.
1994: Schweiger M J; McMahon R P; Terrin M L; Ruocco N A; Porway M N; Wiseman A H; Knatterud G L; Braunwald E
Comparison of patients with < 60% to > or = 60% diameter narrowing of the myocardial infarct-related artery after thrombolysis. The TIMI Investigators.
The American journal of cardiology 1994;74(2):105-10.
1994: Knatterud G L; Bourassa M G; Pepine C J; Geller N L; Sopko G; Chaitman B R; Pratt C; Stone P H; Davies R F; Rogers W J
Effects of treatment strategies to suppress ischemia in patients with coronary artery disease: 12-week results of the Asymptomatic Cardiac Ischemia Pilot (ACIP) study.
Journal of the American College of Cardiology 1994;24(1):11-20.
1994: Pepine C J; Geller N L; Knatterud G L; Bourassa M G; Chaitman B R; Davies R F; Day P; Deanfield J E; Goldberg A D; McMahon R P
The Asymptomatic Cardiac Ischemia Pilot (ACIP) study: design of a randomized clinical trial, baseline data and implications for a long-term outcome trial.
Journal of the American College of Cardiology 1994;24(1):1-10.
1994: Becker R C; Terrin M; Ross R; Knatterud G L; Desvigne-Nickens P; Gore J M; Braunwald E
Comparison of clinical outcomes for women and men after acute myocardial infarction. The Thrombolysis in Myocardial Infarction Investigators.
Annals of internal medicine 1994;120(8):638-45.
1993: Terrin M L; Williams D O; Kleiman N S; Willerson J; Mueller H S; Desvigne-Nickens P; Forman S A; Knatterud G L; Braunwald E
Two- and three-year results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II clinical trial.
Journal of the American College of Cardiology 1993;22(7):1763-72.
1993: Chaitman B R; McMahon R P; Terrin M; Younis L T; Shaw L J; Weiner D A; Frederick M M; Knatterud G L; Sopko G; Braunwald E
Impact of treatment strategy on predischarge exercise test in the Thrombolysis in Myocardial Infarction (TIMI) II Trial.
The American journal of cardiology 1993;71(2):131-8.
1992: Tofler G H; Muller J E; Stone P H; Forman S; Solomon R E; Knatterud G L; Braunwald E
Modifiers of timing and possible triggers of acute myocardial infarction in the Thrombolysis in Myocardial Infarction Phase II (TIMI II) Study Group.
Journal of the American College of Cardiology 1992;20(5):1049-55.
1992: Kleiman N S; Terrin M; Mueller H; Chaitman B; Roberts R; Knatterud G L; Solomon R; McMahon R P; Braunwald E
Mechanisms of early death despite thrombolytic therapy: experience from the Thrombolysis in Myocardial Infarction Phase II (TIMI II) study.
Journal of the American College of Cardiology 1992;19(6):1129-35.
1992: Braunwald E; Knatterud G; Passamani E
The rt-PA versus streptokinase. Controversy--II.
Journal of the American College of Cardiology 1992;19(5):1116-9.
1992: Williams D O; Braunwald E; Knatterud G; Babb J; Bresnahan J; Greenberg M A; Raizner A; Wasserman A; Robertson T; Ross R
One-year results of the Thrombolysis in Myocardial Infarction investigation (TIMI) Phase II Trial.
Circulation 1992;85(2):533-42.
1992: Zaret B L; Wackers F J; Terrin M L; Ross R; Weiss M; Slater J; Morrison J; Bourge R C; Passamani E; Knatterud G
Assessment of global and regional left ventricular performance at rest and during exercise after thrombolytic therapy for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) II Study.
The American journal of cardiology 1992;69(1):1-9.
1991: Gore J M; Sloan M; Price T R; Randall A M; Bovill E; Collen D; Forman S; Knatterud G L; Sopko G; Terrin M L
Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction Study. Thrombolysis in Myocardial Infarction, Phase II, pilot and clinical trial.
Circulation 1991;83(2):448-59.
1991: Roberts R; Rogers W J; Mueller H S; Lambrew C T; Diver D J; Smith H C; Willerson J T; Knatterud G L; Forman S; Passamani E
Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) II-B Study.
Circulation 1991;83(2):422-37.
1990: Feit F; Mueller H S; Braunwald E; Ross R; Hodges M; Herman M V; Knatterud G L
Thrombolysis in Myocardial Infarction (TIMI) phase II trial: outcome comparison of a "conservative strategy" in community versus tertiary hospitals. The TIMI Research Group.
Journal of the American College of Cardiology 1990;16(7):1529-34.
1990: Baim D S; Braunwald E; Feit F; Knatterud G L; Passamani E R; Robertson T L; Rogers W J; Solomon R E; Williams D O
The Thrombolysis in Myocardial Infarction (TIMI) Trial phase II: additional information and perspectives.
Journal of the American College of Cardiology 1990;15(5):1188-92.
1989: Knatterud G L
Thrombolysis in myocardial infarction (TIMI) randomized studies versus TIMI open label studies.
Controlled clinical trials 1989;10(4 Suppl):245S-256S.
1989: Chaitman B R; Thompson B; Wittry M D; Stump D; Hamilton W P; Hillis L D; Dwyer J G; Solomon R E; Knatterud G L
The use of tissue-type plasminogen activator for acute myocardial infarction in the elderly: results from thrombolysis in myocardial infarction Phase I, open label studies and the Thrombolysis in Myocardial Infarction Phase II pilot study. The TIMI Investigators.
Journal of the American College of Cardiology 1989;14(5):1159-65.
1989: Wackers F J; Terrin M L; Kayden D S; Knatterud G; Forman S; Braunwald E; Zaret B L
Quantitative radionuclide assessment of regional ventricular function after thrombolytic therapy for acute myocardial infarction: results of phase I Thrombolysis in Myocardial Infarction (TIMI) trial.
Journal of the American College of Cardiology 1989;13(5):998-1005.
1988: Dalen J E; Gore J M; Braunwald E; Borer J; Goldberg R J; Passamani E R; Forman S; Knatterud G
Six- and twelve-month follow-up of the phase I Thrombolysis in Myocardial Infarction (TIMI) trial.
The American journal of cardiology 1988;62(4):179-85.
1988: Rao A K; Pratt C; Berke A; Jaffe A; Ockene I; Schreiber T L; Bell W R; Knatterud G; Robertson T L; Terrin M L
Thrombolysis in Myocardial Infarction (TIMI) Trial--phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase.
Journal of the American College of Cardiology 1988;11(1):1-11.
1987: Passamani E; Hodges M; Herman M; Grose R; Chaitman B; Rogers W; Forman S; Terrin M; Knatterud G; Robertson T
The Thrombolysis in Myocardial Infarction (TIMI) phase II pilot study: tissue plasminogen activator followed by percutaneous transluminal coronary angioplasty.
Journal of the American College of Cardiology 1987;10(5 Suppl B):51B-64B.
1987: Braunwald E; Knatterud G L; Passamani E; Robertson T L; Solomon R
Update from the Thrombolysis in Myocardial Infarction Trial.
Journal of the American College of Cardiology 1987;10(4):970.
1987: Chesebro J H; Knatterud G; Roberts R; Borer J; Cohen L S; Dalen J; Dodge H T; Francis C K; Hillis D; Ludbrook P
Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.
Circulation 1987;76(1):142-54.
1987: Braunwald E; Knatterud G L; Passamani E R; Robertson T L
Announcement of protocol change in thrombolysis in myocardial infarction trial.
Journal of the American College of Cardiology 1987;9(2):467.
1986: Williams D O; Borer J; Braunwald E; Chesebro J H; Cohen L S; Dalen J; Dodge H T; Francis C K; Knatterud G; Ludbrook P
Intravenous recombinant tissue-type plasminogen activator in patients with acute myocardial infarction: a report from the NHLBI thrombolysis in myocardial infarction trial.
Circulation 1986;73(2):338-46.
1985: Hillis L D; Borer J; Braunwald E; Chesebro J H; Cohen L S; Dalen J; Dodge H T; Francis C K; Knatterud G; Ludbrook P
High dose intravenous streptokinase for acute myocardial infarction: preliminary results of a multicenter trial.
Journal of the American College of Cardiology 1985;6(5):957-62.
1983: Knatterud G L; Forman S A; Canner P L
The Coronary Drug Project. Design of data forms.
Controlled clinical trials 1983;4(4):429-40.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Genell Knatterud

Research Profile (preview)

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Geographic Areas

Activities & Behaviors

Physiology

Phenomena

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Genell Knatterud (preview)

All Publications